Immunotherapy before and during pregnancy improves pregnancy outcome in women who suffer from recurrent abortion and did not benefit from immunotherapy before pregnancy

American Journal of Reproductive Immunology

Volumn 39, Issue 1, 1998, Pages 12-15

  Maejima, Masamoto ^a   Fujii, Tomoyuki ^a   Yamashita, Takahiro ^a   Hara, Naonori ^a   Hamai, Yoko ^a   Miki, Akinori ^a   Kozuma, Shiro ^a   Okai, Takashi ^a   Shibata, Yoichi ^b   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Immunotherapy; Leukocyte; Recurrent abortion

Indexed keywords

ADULT; ARTICLE; CHILDBIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; RECURRENT ABORTION; TREATMENT OUTCOME;

EID: 0031986051     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00327.x     Document Type: Article

References (18)

1. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985; 1:941-943.
2. Taylor CG, Faulk WP: Prevention of recurrent abortion with leukocyte transfusion, Lancet 1981; 2:68-70.
3. Christiansen OB: A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996; 2:271-293.
4. Fujii T, Takamizawa M, Juji T, Kawana T, Mizuno M: Outcome of pregnancy after injection with mononuclear cells. Am J Obstet Gynecol 1988; 158:1015-1016.
5. McIntyre JA, Faulk WP: Maternal blocking factors in human pregnancy are found in plasma not serum. Lancet 1979; 10:821-823.
6. Rocklin R, Kitzmiller JL, Carpenter CB, Garvoy MR, David JR: Maternal-fetal relation: Absence of immunological blocking factor from the serum of women with chronic abortions. N Engl J Med 1976; 295:1209-1213.
7. Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW: Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983; 80:830-834.
8. Kovithavongs T, Dossetor JB: Suppresser cells in human pregnancy. Transplant Proc 1978; 10:911-913.
9. Wegmann TG, Athanassakis I, Guilbert L, Branch D, Dy M, Menu E, Chaouat G: The role of M-CSF and GM-CSF in fostering placental growth, fetal growth, and fetal survival. Transplant Proc 1989; 21:566-568.
10. Hamai Y, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y: Pathogenetical implication of interleukin-2 expressed in preeclamptic decidual tissues: A possible mechanism of deranged vasculature of the placenta associated with preeclampsia. Am J Reprod Immunol 1997; 38:83-88.
11. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y: Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38:89-93.
12. Hara N, Fujii T, Okai T, Taketani Y: Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34:44-51.
13. Fujii T, Tsushirna R, Okai T, Shibata Y, Taketani Y: Allononspecific elevation of maternal killer cell activity towards the intra-uterine growth restricted fetus. Int J Gynecol Obstet 1996; 52:237-242.
14. Labarrere C, Althabe O, Telenta M: Chronic villitis of unknown etiology in placentae of idiopathic small-for-gestational age infants. Placenta 1982; 3:309-317.
15. Lim KJH, Odukoya OA, Li TC, Cooke ID: Cytokines and immuno-endocrine factors in recurrent miscarriage. Hum Reprod Update 1996; 2:469-481.
16. Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
17. Check JH, Tarquini P, Gandy P, Lauer C: A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters. Gynecol Obstet Invest 1995; 39:257-261.
18. Aoki K, Kajiura S, Matsumoto Y, Yagami Y: Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters. Am J Obstet Gynecol 1993; 169:649-653.